{
  "type": "hyp",
  "text": "Preliminary observations also indicate possible correlation with clinical variables such as stage in selected instances. To further characterize altered expression of TCRzeta p56(lck) and impaired activation of NFkappaB T lymphocytes were obtained from 65 patients with RCC the majority of whom were receiving combination cytokine therapy interleukin (IL)-2 IFN alpha-based therapy interleukin (IL)-2 IFN alpha-based and IFNgamma.\n",
  "self": {
    "NER": {
      "answers": [
        "TCRzeta",
        "NFkappaB",
        "65",
        "IFNgamma"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What gene is p56(lck)?",
          "What T lymphocytes were impaired in RCC?",
          "How many patients were analyzed for RCC?",
          "What is the name of the cytokine that is used to treat RCC?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "Preliminary observations",
        "possible correlation",
        "clinical variables",
        "stage",
        "selected instances",
        "altered expression",
        "TCRzeta p56(lck",
        "impaired activation",
        "NFkappaB T lymphocytes",
        "65 patients",
        "RCC",
        "the majority",
        "whom",
        "combination cytokine therapy interleukin",
        "IFN alpha-based therapy interleukin"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What indicates possible correlation with clinical variables?",
          "What do preliminary observations indicate about clinical variables?",
          "What do preliminary observations indicate possible correlation with?",
          "What is a possible correlation with clinical variables?",
          "Preliminary observations indicate possible correlation with clinical variables such as stage in what instances?",
          "What is the effect of TCRzeta p56(lck) on T",
          "What gene was altered in patients with RCC?",
          "What is the effect of NFkappaB T lymphocytes on the inflammatory",
          "What did the study study show was impaired in RCC patients?",
          "How many patients were analyzed for RCC?",
          "What is the most common type of RCC?",
          "What percentage of patients with RCC were receiving combination cytokine therapy?",
          "What patients were most affected by RCC?",
          "What treatment did most patients receive?",
          "What is the name of the cytokine that is used to treat RCC?"
        ]
      }
    }
  },
  "asked": {
    "What gene is p56(lck)?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "TCRzeta",
        "answerability": 0.8067866563796997,
        "ground_truth": {
          "TCRzeta": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What T lymphocytes were impaired in RCC?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "NFkappaB",
        "answerability": 0.5343834161758423,
        "ground_truth": {
          "NFkappaB": {
            "bertscore": 0.9999998807907104,
            "f1": 1.0
          }
        }
      }
    },
    "How many patients were analyzed for RCC?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "65",
        "answerability": 0.962471067905426,
        "ground_truth": {
          "65": {
            "bertscore": 1.0,
            "f1": 1.0
          },
          "65 patients": {
            "bertscore": 0.6448143124580383,
            "f1": 0.6666666666666666
          }
        }
      }
    },
    "How many control individuals were given IL-2 IFN alpha?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.01592046022415161,
        "ground_truth": {
          "37": {
            "bertscore": 0.5732170343399048,
            "f1": 0
          }
        }
      }
    },
    "What indicates possible correlation with clinical variables?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "Preliminary observations",
        "answerability": 0.9956730604171753,
        "ground_truth": {
          "Preliminary observations": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What do preliminary observations indicate about clinical variables?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "possible correlation",
        "answerability": 0.92453932762146,
        "ground_truth": {
          "possible correlation": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What do preliminary observations indicate possible correlation with?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "clinical variables",
        "answerability": 0.9984579682350159,
        "ground_truth": {
          "clinical variables": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What is a possible correlation with clinical variables?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "stage",
        "answerability": 0.9811726212501526,
        "ground_truth": {
          "stage": {
            "bertscore": 0.9999998807907104,
            "f1": 1.0
          }
        }
      }
    },
    "Preliminary observations indicate possible correlation with clinical variables such as stage in what instances?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "selected instances",
        "answerability": 0.9889026880264282,
        "ground_truth": {
          "selected instances": {
            "bertscore": 1.0000001192092896,
            "f1": 1.0
          }
        }
      }
    },
    "What is the effect of TCRzeta p56(lck) on T": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.3842895030975342,
        "ground_truth": {
          "altered expression": {
            "bertscore": 0.7370376586914062,
            "f1": 0
          }
        }
      }
    },
    "What gene was altered in the patients with RCC?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "TCRzeta p56(lck)",
        "answerability": 0.8549646139144897,
        "ground_truth": {
          "TCRzeta p56(lck": {
            "bertscore": 0.9444116950035095,
            "f1": 1.0
          }
        }
      }
    },
    "What is the effect of NFkappaB T lymphocytes on the inflammatory": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.4858509302139282,
        "ground_truth": {
          "impaired activation": {
            "bertscore": 0.7293853759765625,
            "f1": 0
          }
        }
      }
    },
    "What did the study study show was impaired in RCC patients?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "activation of NFkappaB T lymphocytes",
        "answerability": 0.9533534049987793,
        "ground_truth": {
          "NFkappaB T lymphocytes": {
            "bertscore": 0.8969656825065613,
            "f1": 0.7499999999999999
          }
        }
      }
    },
    "What is the most common type of RCC?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.017058074474334717,
        "ground_truth": {
          "RCC": {
            "bertscore": 0.6816695928573608,
            "f1": 0
          }
        }
      }
    },
    "How many patients were receiving combination cytokine therapy?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "65",
        "answerability": 0.6815199851989746,
        "ground_truth": {
          "the majority": {
            "bertscore": 0.5650523900985718,
            "f1": 0
          }
        }
      }
    },
    "Who was the majority of patients with RCC?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.04348856210708618,
        "ground_truth": {
          "whom": {
            "bertscore": 0.6851019263267517,
            "f1": 0
          }
        }
      }
    },
    "What is IL-2?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.6529511213302612,
        "ground_truth": {
          "combination cytokine therapy interleukin": {
            "bertscore": 0.5972957611083984,
            "f1": 0
          }
        }
      }
    }
  }
}